会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Composition and method for treating cancer
    • 用于治疗癌症的组合物和方法
    • US07074825B2
    • 2006-07-11
    • US10383811
    • 2003-03-07
    • Huanbiao MoCharles E. ElsonDennis M. PeffleyPatricia M. Hentosh
    • Huanbiao MoCharles E. ElsonDennis M. PeffleyPatricia M. Hentosh
    • A61K31/35A61K31/335
    • A61K45/06
    • A composition and an associated method of treating cancer cells by impeding cancer cell growth with the composition are disclosed. The composition includes at least a first and a second HMG-CoA reductase inhibitor, wherein the total amount of the first and second HMG-CoA reductase inhibitors is effective in synergistically impeding cancer cell growth and wherein the cancer cell growth synergistic impedance from the total amount of the first and second HMG-CoA reductase inhibitors is greater than a theoretical additive effect from the combined first and second HMG-CoA reductase inhibitors. The present composition does not simultaneously contain both a tocotrienol and an ionone when the composition contains only a first and a second HMG-CoA reductase inhibitor. The method includes treating cancer cells with the claimed composition to impede cancer cell growth.
    • 公开了通过阻止癌细胞生长与组合物来治疗癌细胞的组合物和相关方法。 所述组合物包含至少第一和第二HMG-CoA还原酶抑制剂,其中所述第一和第二HMG-CoA还原酶抑制剂的总量有效协同地阻碍癌细胞生长,并且其中所述癌细胞生长协同阻抗从总量 的第一和第二HMG-CoA还原酶抑制剂大于来自组合的第一和第二HMG-CoA还原酶抑制剂的理论叠加效应。 当组合物仅含有第一和第二HMG-CoA还原酶抑制剂时,本发明组合物不同时含有生育三烯酚和紫罗酮。 该方法包括用所要求保护的组合物治疗癌细胞以阻止癌细胞生长。